US Stock MarketDetailed Quotes

EVFM Evofem Biosciences

Watchlist
  • 0.015
  • +0.002+16.04%
15min DelayClose Apr 24 15:58 ET
684.50KMarket Cap0.30P/E (TTM)

About Evofem Biosciences Company

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

Company Profile

SymbolEVFM
Company NameEvofem Biosciences
Listing DateNov 20, 2014
Issue Price14.00
Founded2007
CEOMs. Saundra Pelletier
MarketPink Market
Employees38
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7770 Regents Road,Suite 113-618
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92122
Phone1-858-550-1900
Websitehttp://www.evofem.com

Company Executives

  • Name
  • Position
  • Salary
  • Saundra Pelletier
  • Interim Chairman of the Board, President and Chief Executive Officer
  • 3.19M
  • Justin J. File
  • Chief Financial Officer and Principal Accounting Officer
  • 1.26M
  • Tony O’Brien
  • Independent Director
  • 163.23K
  • Jenny Yip
  • Independent Director
  • --
  • Colin Rutherford
  • Independent Director
  • 158.23K
  • Dr. Gillian Greer, PhD
  • Independent Director
  • 150.73K
  • Dr. Lisa Dale Rarick, F.A.C.O.G.
  • Independent Director
  • 140.35K
  • Dr. Kim P. Kamdar
  • Independent Director
  • 159.48K
  • Alexander A. Fitzpatrick, Esq.
  • General Counsel and Secretary
  • 1.05M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg